Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Aug-24 4:10 PM View:  | Denali Therapeutics Inc. (DNLI) | 13-Aug-24 | Sale | 2,272 | $22.89 | $52,006.10 | (< 1%) 712.44K to 710.17K | |
| 15-Feb-24 9:14 PM View: | Denali Therapeutics Inc. (DNLI) | 14-Feb-24 | Sale (Planned) | 20,128 | $17.66 | $355,460.00 | (3%) 731.22K to 711.09K | |
| 15-Feb-24 9:14 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-24 | Sale | 2,716 | $17.29 | $46,959.60 | (< 1%) 733.93K to 731.22K | |
| 12-Feb-24 4:48 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Feb-24 | Option Exercise | 50,000 | $0.68 | $34,000.00 | 7% 683.93K to 733.93K | |
| 09-Jan-24 7:34 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-24 | Sale | 9,972 | $19.43 | $193,756.00 | (1%) 693.91K to 683.93K | |
| 05-Jan-24 5:57 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-24 | Grant | 53,720 | -- | -- | 8% 640.19K to 693.91K | |
| 25-Aug-23 5:36 PM View: | Denali Therapeutics Inc. (DNLI) | 23-Aug-23 | Sale (Planned) | 2,522 | $23.17 | $58,434.70 | (< 1%) 642.71K to 640.19K | |
| 23-Aug-23 4:33 PM View: | Denali Therapeutics Inc. (DNLI) | 21-Aug-23 | Sale | 2,478 | $22.59 | $55,978.00 | (< 1%) 645.19K to 642.71K | |
| 16-Aug-23 6:19 PM View: | Denali Therapeutics Inc. (DNLI) | 14-Aug-23 | Sale (Planned) | 2,772 | $23.67 | $65,613.20 | (< 1%) 647.96K to 645.19K | |
| 14-Aug-23 5:11 PM View: | Denali Therapeutics Inc. (DNLI) | 10-Aug-23 | Sale | 2,853 | $24.18 | $68,985.50 | (< 1%) 650.81K to 647.96K | |
| 19-Jul-23 5:10 PM View: | Denali Therapeutics Inc. (DNLI) | 18-Jul-23 | Sale (Planned) | 9,702 | $30.01 | $291,157.00 | (1%) 660.51K to 650.81K | |
| 19-Jul-23 5:10 PM View: | Denali Therapeutics Inc. (DNLI) | 17-Jul-23 | Option Exercise | 10,000 | $5.28 | $52,800.00 | 2% 660.51K to 670.51K | |
| 19-Jul-23 5:10 PM View: | Denali Therapeutics Inc. (DNLI) | 17-Jul-23 | Planned Option Sale | 10,000 | $29.60 | $296,000.00 | (1%) 670.51K to 660.51K | |
| 17-May-23 4:56 PM View: | Denali Therapeutics Inc. (DNLI) | 15-May-23 | Option Exercise | 10,000 | $5.28 | $52,800.00 | 2% 659.48K to 669.48K | |
| 17-May-23 4:56 PM View: | Denali Therapeutics Inc. (DNLI) | 15-May-23 | Planned Option Sale | 10,000 | $28.60 | $286,044.00 | (1%) 669.48K to 659.48K | |
| 14-Apr-23 6:27 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Apr-23 | Option Exercise | 4,898 | $5.28 | $25,861.40 | < 1% 659.48K to 664.38K | |
| 14-Apr-23 6:27 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Apr-23 | Planned Option Sale | 4,898 | $25.04 | $122,646.00 | (< 1%) 664.38K to 659.48K | |
| 14-Apr-23 6:27 PM View: | Denali Therapeutics Inc. (DNLI) | 12-Apr-23 | Option Exercise | 5,102 | $5.28 | $26,938.60 | < 1% 659.48K to 664.59K | |
| 14-Apr-23 6:27 PM View: | Denali Therapeutics Inc. (DNLI) | 12-Apr-23 | Planned Option Sale | 5,102 | $25.04 | $127,754.00 | (< 1%) 664.59K to 659.48K | |
| 15-Feb-23 7:01 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-23 | Option Exercise Duplicate | 25,000 | $0.68 | $17,000.00 | 4% 637.98K to 662.98K | |
| 15-Feb-23 7:01 PM View: | Denali Therapeutics Inc. (DNLI) | 13-Feb-23 | Option Sale | 3,497 | $30.09 | $105,225.00 | (< 1%) 662.98K to 659.48K | |
| 10-Feb-23 6:11 PM View: | Denali Therapeutics Inc. (DNLI) | 08-Feb-23 | Sale | 1,521 | $30.89 | $46,983.70 | (< 1%) 639.5K to 637.98K | |
| 19-Jan-23 5:09 PM View: | Denali Therapeutics Inc. (DNLI) | 17-Jan-23 | Option Exercise | 10,000 | $5.28 | $52,800.00 | 2% 639.5K to 649.5K | |
| 19-Jan-23 5:09 PM View: | Denali Therapeutics Inc. (DNLI) | 17-Jan-23 | Planned Option Sale | 10,000 | $29.53 | $295,339.00 | (2%) 649.5K to 639.5K | |
| 09-Jan-23 9:41 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-23 | Sale | 2,636 | $28.44 | $74,967.80 | (< 1%) 642.14K to 639.5K | |
| 05-Jan-23 10:00 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Jan-23 | Sale | 2,912 | $28.70 | $83,574.40 | (< 1%) 645.05K to 642.14K | |
| 05-Jan-23 10:00 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-23 | Grant | 41,120 | -- | -- | 7% 608.77K to 649.89K | |
| 12-Oct-22 4:05 PM View: | Denali Therapeutics Inc. (DNLI) | 07-Oct-22 | Option Exercise | 20,000 | $0.68 | $13,600.00 | 3% 583.93K to 603.93K | |
| 23-Aug-22 4:46 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Aug-22 | Sale Duplicate | 2,576 | $33.22 | $85,574.70 | (< 1%) 586.5K to 583.93K | |
| 11-Aug-22 7:21 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Aug-22 | Grant | 22,500 | -- | -- | 4% 564.0K to 586.5K | |
| 15-Feb-22 6:55 PM View: | Denali Therapeutics Inc. (DNLI) | 11-Feb-22 | Sale | 2,803 | $34.68 | $97,208.00 | (< 1%) 566.27K to 563.47K | |
| 11-Feb-22 5:18 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-22 | Market Sale | 1,423 | $37.10 | $52,799.70 | (< 1%) 567.69K to 566.27K | (9%) |
| 07-Jan-22 6:05 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Jan-22 | Market Sale | 2,846 | $44.77 | $127,415.00 | (< 1%) 570.54K to 567.69K | 2% |
| 05-Jan-22 7:04 PM View: | Denali Therapeutics Inc. (DNLI) | 03-Jan-22 | Grant | 31,000 | -- | -- | 6% 539.54K to 570.54K | |
| 08-Dec-21 5:35 PM View: | Denali Therapeutics Inc. (DNLI) | 06-Dec-21 | Market Sale (Planned) | 10,000 | $42.27 | $422,736.00 | (2%) 549.54K to 539.54K | (5%) |
| 08-Nov-21 4:16 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Nov-21 | Market Sale (Planned) | 10,000 | $52.84 | $528,404.00 | (2%) 559.54K to 549.54K | (4%) |
| 06-Oct-21 6:14 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Oct-21 | Market Sale (Planned) | 10,000 | $50.56 | $505,605.00 | (2%) 569.54K to 559.54K | < 1% |
| 22-Sep-21 10:00 PM View: | Denali Therapeutics Inc. (DNLI) | 20-Sep-21 | Option Exercise | 9,045 | $0.68 | $6,150.60 | 2% 560.49K to 569.54K | |
| 09-Sep-21 5:08 PM View: | Denali Therapeutics Inc. (DNLI) | 07-Sep-21 | Market Sale (Planned) | 10,000 | $55.55 | $555,485.00 | (2%) 570.49K to 560.49K | 4% |
| 23-Aug-21 8:25 PM View: | Denali Therapeutics Inc. (DNLI) | 19-Aug-21 | Market Sale | 2,544 | $49.60 | $126,186.00 | (< 1%) 573.04K to 570.49K | 1% |
| 06-Aug-21 4:09 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Aug-21 | Market Sale (Planned) | 10,000 | $52.22 | $522,233.00 | (2%) 583.04K to 573.04K | (1%) |
| 08-Jul-21 4:06 PM View: | Denali Therapeutics Inc. (DNLI) | 06-Jul-21 | Market Sale (Planned) | 10,000 | $76.20 | $762,040.00 | (2%) 593.04K to 583.04K | (< 1%) |
| 08-Jun-21 5:10 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Jun-21 | Market Sale (Planned) | 10,000 | $64.55 | $645,500.00 | (2%) 603.04K to 593.04K | (11%) |
| 06-May-21 6:50 PM View: | Denali Therapeutics Inc. (DNLI) | 04-May-21 | Market Sale (Planned) | 10,000 | $55.49 | $554,864.00 | (2%) 612.63K to 602.63K | 4% |
| 06-Apr-21 8:39 PM View: | Denali Therapeutics Inc. (DNLI) | 05-Apr-21 | Market Sale (Planned) | 10,000 | $56.09 | $560,901.00 | (2%) 622.63K to 612.63K | 1% |
| 04-Mar-21 6:38 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Mar-21 | Market Sale (Planned) | 10,000 | $61.02 | $610,172.00 | (2%) 632.63K to 622.63K | (< 1%) |
| 16-Feb-21 7:43 PM View: | Denali Therapeutics Inc. (DNLI) | 11-Feb-21 | Market Sale | 3,047 | $70.35 | $214,341.00 | (< 1%) 635.67K to 632.63K | 4% |
| 11-Feb-21 7:13 PM View: | Denali Therapeutics Inc. (DNLI) | 09-Feb-21 | Market Option Sale | 1,468 | $74.80 | $109,809.00 | (< 1%) 549.5K to 548.03K | |
| 11-Feb-21 7:13 PM View: | Denali Therapeutics Inc. (DNLI) | 07-Feb-21 | Option Exercise Duplicate | 4,250 | -- | -- | < 1% 545.25K to 549.5K | |
| 05-Feb-21 4:44 PM View: | Denali Therapeutics Inc. (DNLI) | 04-Feb-21 | Market Sale (Planned) | 10,000 | $67.84 | $678,361.00 | (2%) 555.25K to 545.25K | (3%) |